Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anastassiades

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Clinical Nephrology|May 1, 1981
Dialysis encephalopathy: precipitating factors and improvement in prognosisM M Platts, E Anastassiades
The Journal of Infection|May 1, 1989
Cryptococcosis complicating continuous ambulatory peritoneal dialysisE B Kaczmarski, J A Tooth, E Anastassiades, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparinE Anastassiades, H Ireland, A Flynn, et al.
Haemostasis|January 1, 1986
On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failureD A Lane, A Flynn, H Ireland, et al.
British Medical Journal (Clinical Research Ed.)|November 24, 1984
Spleen size in chronic renal failureM M Platts, E Anastassiades, S Sheriff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986
Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formationD A Lane, H Ireland, A Flynn, et al.
Clinical Nephrology|December 1, 1989
A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparinE Anastassiades, D A Lane, H Ireland, et al.
Thrombosis and Haemostasis|April 30, 1986
The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessmentH Ireland, D A Lane, A Flynn, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1992
Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemiaJ Auer, G Simon, J Stevens, et al.
Clinical Science (London, England : 1979)|December 1, 1987
Is hypercapnia necessary for the ventilatory response to exercise in man?K Murphy, R P Stidwill, B A Cross, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Nephrology|May 1, 1981
Dialysis encephalopathy: precipitating factors and improvement in prognosisM M Platts, E Anastassiades
The Journal of Infection|May 1, 1989
Cryptococcosis complicating continuous ambulatory peritoneal dialysisE B Kaczmarski, J A Tooth, E Anastassiades, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1990
A low-molecular-weight heparin (Kabi 2165, 'Fragmin') in repeated use for haemodialysis: prevention of clotting and prolongation of the venous compression time in comparison with commercial unfractionated heparinE Anastassiades, H Ireland, A Flynn, et al.
Haemostasis|January 1, 1986
On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failureD A Lane, A Flynn, H Ireland, et al.
British Medical Journal (Clinical Research Ed.)|November 24, 1984
Spleen size in chronic renal failureM M Platts, E Anastassiades, S Sheriff, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1986
Haemodialysis with low MW heparin: dosage requirements for the elimination of extracorporeal fibrin formationD A Lane, H Ireland, A Flynn, et al.
Clinical Nephrology|December 1, 1989
A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparinE Anastassiades, D A Lane, H Ireland, et al.
Thrombosis and Haemostasis|April 30, 1986
The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessmentH Ireland, D A Lane, A Flynn, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1992
Quality of life improvements in CAPD patients treated with subcutaneously administered erythropoietin for anemiaJ Auer, G Simon, J Stevens, et al.
Clinical Science (London, England : 1979)|December 1, 1987
Is hypercapnia necessary for the ventilatory response to exercise in man?K Murphy, R P Stidwill, B A Cross, et al.
Pageof 2